Clinical Presentation
Symptoms on presentation correlated with the location of the cysts. Epileptic seizures (partial simple, complex, and secondarily generalized seizures) occurred in 46 patients (74%). All patients harboring single inflammatory parenchymal cysts (25 cases) and 21 of 35 patients harboring multiple parenchymal, subarachnoid, and intraventricular cysts presented with epileptic seizures. Of the 35 patients with multiple lesions, 16 (46%) also harbored intraventricular cysts. In two of the 18 cases with IVNCC, single or multiple fourth ventricular cysts were present without parenchymal cysts, and in 16 cases, intraventricular cysts were present in combination with parenchymal cysts. Hydrocephalus was present in all patients with intraventricular cysts, and all presented with symptoms of increased ICP and/or meningitis. Three patients with intraventricular cysts also suffered epileptic seizures. Two patients with multiple parenchymal cysts who presented with seizures also experienced mild hemiparesis.
Neuroimaging Studies
All patients underwent CT or MR imaging of the brain, the latter being the imaging modality of choice. Examples are given in the figures, and we further detail imaging characteristics in the Discussion section.
Immunodiagnostic Studies
Enzyme-linked immunosorbent assay of serum was performed in 33 patients; however, this test was discontinued in 1998 because the rate of positive findings was only 55% (18 patients). Enzyme-linked immunoelectrotransfer blot of serum and CSF, obtained by lumbar puncture or ventriculostomy, was performed in 35 patients. Results for NCC were positive in 80% of patients: nine of nine with intraventricular cysts, seven of seven with subarachnoid cysts and meningitis, and 11 of 19 with parenchymal cysts. In nine patients with intraventricular cysts, serum EITB and brain neuroimaging findings were considered sufficient for establishing the diagnosis. 1, 42, 50 
Tissue Diagnosis
In two patients, specimens were obtained from a single parenchymal lesion; in another two patients, specimens were obtained from single or multiple fourth ventricular cysts. In four patients, specimens were obtained from multiple cysts in the posterior fossa and in six, specimens were obtained through ventriculostomy. All tissue findings were positive for NCC.
Treatment and Outcome
Treatment was symptom specific and varied according to several factors: 1) location and stage of evolution of the cysts; 2) clinical status of the patient; 3) patient's preference; 4) presence of hydrocephalus; and 5) attending physician's preference and experience. Treatment included administration of anthelmintic drugs (all patients received albendazole; praziquantel was not used in this series) in combination with steroid agents, emergency ventriculostomy, resection of the cysts, VP shunt placement, and combinations of these methods.
In 10 of the 18 patients a VP shunt was placed. In three of these 10 viable fourth ventricular cysts were resected, and in two others the cysts were excised from elsewhere in the ventricular system. Six of the ten VP shunts required revision within 3 years. Two patients died of progressive hydrocephalus despite having undergone shunt placement.
In the eight patients with minimal or no hydrocephalus in whom initial treatment did not include shunt placement, the cysts resolved with albendazole treatment. In one patient, however, hydrocephalus developed 2 years later due to adhesions and scarring, and subsequent treatment with a VP shunt was successful. One patient with an asymptomatic cyst died of acute hydrocephalus following a vaginal hysterectomy; in Juarez, Mexico another patient died of meningitis after undergoing the placement of a VP shunt to treat hydrocephalus that developed 1 year after initial diagnosis and treatment at TTUHSC.
DISCUSSION
The development of an active cysticercus, from the time the eggs are ingested, is completed within 60 to 70 days. 6 Cysts can be parenchymal, subarachnoid, or intraventricular. A viable larva in an active-phase cyst can live up to 7 years. 6 A useful classification of NCC is that proposed by Carpio, et al.;
11 active (vesicular, viable), inflammatory (involutional, transitional, colloidal), and inactive lesions. Active cysts usually do not cause clinical symptoms unless located in areas of the brain where they may cause seizures or hydrocephalus. Active intraventricular cysts may persist for years but become symptomatic if they obstruct CSF flow, with consequent hydrocephalus and increased ICP. The lateral ventricles and the fourth ventricle are the most common locations for IVNCC.
Intraventricular cysts have a more aggressive behavior than their parenchymal counterparts. Symptoms associated with the parenchymal lesions largely result from the host's inflammatory response to the dead or dying larva; irritation and edema of the brain and epileptic seizures may develop.
Intraventricular cysts may become symptomatic at the time of implantation secondary to obstruction of CSF flow, with consequent hydrocephalus and the symptoms and signs of increased ICP. When involution begins, the inflammatory reaction around a dead or dying cyst produces ependymitis, scarring, obstruction, and ventriculitis.
Clinical Presentations
Parenchymal Cysts. Parenchymal symptomatic NCC is largely a result of host inflammatory response, usually presenting, as in our series, with epileptic seizures. A good prognosis is associated with parenchymal inflammatory disease. The secondary symptomatology of coexisting parenchymal involutional cysts may lead to the discovery of asymptomatic intraventricular cysts with or without hydrocephalus. Thus, there are patients who present with tonic-clonic generalized seizures or partial seizures secondary to parenchymal involutional cysts, in whom intraventricular asymptomatic cysts are also present (Fig. 1). A. C. Cuetter and R. J. Andrews Abrupt CSF obstruction results in acute hydrocephalus, in which symptoms and signs include headache, diplopia, dizziness, vomiting, restlessness, seizures, respiratory changes, bradycardia, blood pressure elevation, and alteration of consciousness.
Abrupt intermittent obstruction of CSF flow may last hours to days. Sudden alterations of head position may change the location of the cyst, triggering or alleviate headaches, or producing a fleeting loss of strength or muscle tone. 26, 31, 33 These drop attacks may be due to associated sudden bilateral ischemic changes in the brainstem.
Abrupt permanent obstruction may cause acute hydrocephalus leading to stupor, coma, and death due to brain herniation. 4, 26, 31, 33, 44 Sites of obstruction include the foramen of Monro, third ventricle, aqueduct of Sylvius, and fourth ventricle. 4 Noncommunicating hydrocephalus may require emergency intervention to prevent brain herniation. Direct compression of the brainstem and midline cerebellar structures secondary to fourth ventricular obstruction may produce, in addition to symptoms of increased ICP, focal deficits such as gait ataxia, dysmetria, and diplopia. 15, 20 In children this clinical presentation may resemble that of a midline cerebellar tumor. Obstruction of the aqueduct of Sylvius may produce a superior aqueductal syndrome, in which paralysis of vertical gaze as well as other symptoms and signs of increased ICP occur. 47 Chronic obstruction can produce an insidious increase in ICP. 31 If not treated, patients thus afflicted may deteriorate abruptly. 33 Frequently the obstruction is due to a large cyst in the fourth ventricle. Symptoms include headache, nausea, vomiting, somnolence, memory and behavioral changes, and gait disturbance, and they may be present for several months prior to diagnosis. 5, 31, 33, 44 Findings include decreased alertness, papilledema, and focal motor deficits, including corticospinal tract signs and frontal lobe motor apraxia. The latter is the result of extensive bilateral lesions of frontal lobe long motor tracts in the internal capsule that are caused by enlarged lateral ventricles, the ventricular expansion being maximal in the frontal horns.
Obstruction of CSF Flow-and Inflammation-Related Symptoms.
Patients who experience symptoms secondary to CSF obstruction and inflammation are the most likely to die of chronic complications. An asymptomatic intraventricular cyst becomes symptomatic when the cyst larva dies, resulting in involution and inflammation. The involutional cyst liberates antigenic substances that cause an inflammatory reaction throughout the ventricular system. This granular ependymitis fixes the cyst capsule to the ventricular wall with strong adhesions and fibrosis. The resulting progressive hydrocephalus and increased ICP may prove fatal (especially in the fourth ventricle), in part because fixed cysts may not be amenable to excision without damage to adjacent brain tissue. 32, 37, 39 Patients present with increased ICP, meningoencephalitis (fever, alteration of consciousness, nuchal rigidity), focal neurological deficit, and inflammatory reaction detectable in the CSF. 29, 39 Even with provision of appropriate treatment, mental deterioration, blindness, quadriparesis, and ataxia may occur. 29 Complications include cerebral and brainstem infarction due to angiitis, hypothalamic dysfunction, infections, repeated shunt failure, arachnoiditis, ependymitis, and ventriculitis.
Inflammatory fourth ventricular cysts can be associated with widespread granular ependymitis and ventriculitis. The ventricular enlargement may persist after a VP shunt is placed to treat the hydrocephalus. 39 There may be single or multiple involutional cysts in the fourth ventricle, but occasionally no cysts are found either on neuroimaging studies or at surgery.
Clinically similar to IVNCC, but more appropriately termed meningeal NCC, is basilar arachnoiditis and leptomeningeal scarring that can cause communicating hydrocephalus. This communicating hydrocephalus can manifest the same symptoms, neurological deficits, and fatal outcome as noncommunicating hydrocephalus.
Neuroimaging and Laboratory Diagnosis
The diagnosis of IVNCC is based on clinical presentation, MR imaging evidence of cystic lesions containing the scolex, and isolating the parasite histologically from the brain lesions or the CSF. 21 Because the clinical presentation of IVNCC is nondiagnostic, one must review a patient's history, laboratory findings, and neuroimaging studies to confirm the diagnosis.
Neuroimaging Studies. For several reasons CT scanning may fail to demonstrate small cysts that do not deform the ventricles: 1) they share the same density as CSF; 2) the cyst wall and the scolex are not visible; and 3) the cyst does not show contrast enhancement. 28, 30, 52 A large intraventricular cyst may be seen on CT scans, even without hydrocephalus, if it deforms the ventricle and the cyst is outlined by the normal ventricular cavity. A cyst deforming or enlarging the fourth ventricle is usually well visualized on CT scans if narrow (3-or 5-mm) slices are obtained. Edema of the adjacent tissues is frequently present if the cyst is in the inflammatory stage (Fig. 2) . diagnosis is facilitated by finding cysts in different stages of evolution, including calcifications, as well as the presence of hydrocephalus, even if the obstructing cysts are not visualized.
Magnetic resonance imaging is the most important neuroimaging study, revealing intraventricular cysts in approximately 80% of cases. 13 A viable active intraventricular cyst appears as a spherical lesion of 10 to 20 mm in diameter on T 1 -weighted and fluid-attenuated inversionrecovery imaging. The scolex is frequently demonstrated as a mural nodule having the hyperintensity of fat. A cystic lesion with a scolex is one of the absolute diagnostic criteria. 24 The cyst wall appears as a thin hyperinten-sity between the darkness of the cyst content and the CSF. On T 2 -weighted imaging, the cyst contents are isointense with the surrounding tissues, and the scolex is hyperintense.
The granular ependymitis that accompanies inflammatory, involutional cysts shows ringlike or nodular enhancement. The inflammatory features of an involutional cyst are demonstrated on T 1 -weighted MR imaging without gadolinium administration. Features include: 1) hyperintense cyst wall ( Fig. 3 left) ; 2) hyperintense scolex ( Fig.  3 right) ; and 3) edema around the cyst (Fig. 3 left) . Inflammatory intraventricular cysts have ring enhancement with surrounding edema similar to inflammatory parenchymal cysts visualized on contrast-enhanced T 1 -weighted MR imaging (Fig. 1 left) . 52 Neuroimaging alone may not be sufficient to differentiate ring-enhancing IVNCC lesion from a neoplastic or other inflammatory process. 52 Occasionally there may be hydrocephalus and other MR imaging-documented findings in cases of IVNCC, but no intraventricular cysts are observed. Ventricular dilation may be secondary to ependymitis, scarring, or meningeal involvement. Unilateral ventricular enlargement may result from a cyst in the third ventricle or the foramen of Monro. Fourth ventricular cysts often produce hydrocephalus, but, for unexplained reasons, usually are not accompanied by parenchymal cysts.
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Laboratory Studies. The primary immunodiagnostic methods for diagnosing NCC are the EITB and the enzyme-linked immunosorbent assay. 1, 42, 50 Whereas these tests are highly sensitive in multiple inflammatory lesions, they are not so in those with single viable lesions. In over 80% of patients with intraventricular inflammatory lesions, EITB assays both are positive for NCC in serum and in CSF, regardless of the number or apparent condition of the cysts. 50 The enzyme-linked immunosorbent assay has a high rate of both false-positive and false-negative results. 1, 42 Immunodiagnostic tests may yield falsepositive reactions in tuberculosis, as well as in parasitic diseases such as echinococcis. 42 Lumbar puncture is contraindicated in patients in whom increased ICP is suspected. A ventriculostomy may provide an aid to diagnosis as well as therapeutic drainage. Cerebrospinal fluid abnormalities are directly proportional to the degree of local inflammation and ventriculitis. In 50% of cases the CSF cell count, protein, and glucose are normal. 33 In the other 50% a moderate mixed pleocytosis, increased protein, and hypoglycorrhagia are seen. Pleocytosis is more commonly lymphomonuclear than polymorphonuclear, with eosinophilia occurring in approximately 20% of cases. 9, 31, 33, 44 Glucose is reduced in approximately 6% of cases; protein may be elevated up to 420 mg/dl. 12, 44 An important diagnostic criterion is histological demonstration of the parasite. The tissue may be obtained from the surgically removed cyst or from intraventricular contents obtained through ventriculostomy.
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Differential Diagnosis. The differential diagnosis of IVNCC includes toxoplasmosis, fungal and bacterial meningitis, hydrocephalic sequelae of tuberculous meningitis, echinococcosis, intraventricular neoplasms, and noninfectious granulomatous chronic meningitis. 1, 16, 20, 54 Toxoplasmosis may present with enlarged ventricles caused by ependymitis and aqueductal stenosis; parenchymal calcifications may resemble cysticercosis. 30 Although bacterial and coccidioidal ependymitis with ventriculitis can produce hydrocephalus and associated enhancement of the ependymal ventricular walls, the clinical picture combined with the absence of cysts or other signs of NCC make differentiation relatively easy. Granulomatous tuberculous meningitis may present with hydrocephalus, but involvement of the basal meninges on postgadolinium MR imaging is much more common than in IVNCC. 8, 43 A. C. Cuetter and R. J. Andrews The multiloculated parenchymal cystic structure of echinococcosis may resemble IVNCC on MR imaging. A third ventricular cysticercal lesion (Fig. 4) may mimic a colloid cyst. 51 Fourth ventricle cysts may appear as neoplasms such as cystic medulloblastoma, astrocytoma, or ependymoma, with CSF obstruction and edema of adjacent brain (Figs. 2 and 3 left) . Characteristics indicating diagnosis of a tumor over IVNCC include the presence of: 1) contrast enhancement; 2) more edema in the adjacent tissues; and 3) extension up and down the fourth ventricle and laterally into the prepontine cisterns. Other conditions such as sarcoidosis and meningeal carcinomatosis, which produce leptomeningitis and pachymeningitis, may also cause chronic hydrocephalus. 30 
Treatment of IVNCC
The treatment of IVNCC is tailored to the presenting symptoms. The optimum treatment selected from the following therapeutic modalities depends on several factors, including the patient's condition, location of the cysts, and evolutional stage of the cysts: 1) emergency ventriculostomy; 2) placement of a VP shunt; 3) endoscopic or open extirpation of obstructing cysts; 4) antihelmintic medications (albendazole and praziquantel); 5) steroid therapy; and 6) antiepileptic medications.
Acute hydrocephalus usually requires ventriculostomy and subsequent resection of the cysts obstructing CSF flow, particularly those in the fourth ventricle. 4, 7, 32, 33, 39, 45, 52 Whether to choose endoscopic or open resection depends on the surgeon's experience; the less invasive endoscopic removal being preferred in most situations.
Involutional inflammatory cysts are attached to the ventricular wall by strong adhesions and cannot easily be removed without damaging adjacent brain tissue. 3, 4, 32, 39 Removal of the cyst does not typically obviate the need for a shunt. 4, 16 Thus, when neuroimaging evidence of ependymitis exists, the preferred treatment is placement of a VP shunt without removal of the cyst.
Although differentiation between a viable and an inflammatory intraventricular cyst is usually difficult, the following may prove helpful. Viable cysts do not provoke symptoms or signs of meningitis, and they produce no or only discrete inflammatory reaction on examination of CSF samples. An involutional inflammatory cyst typically shows symptoms and signs of meningitis, focal neurological deficit, and inflammatory response on examination of CSF. 39 On T 1 -weighted noncontrast MR images, an inflammatory cyst has a hyperintense wall and edema of adjacent brain tissue (Fig. 3 left) , whereas on T 1 -weighted postcontrast MR images there is a ring enhancement in the cyst wall (Fig. 1 upper) .
Emergency ventriculostomy, typically followed by insertion of a VP shunt, is indicated in patients with acute hydrocephalus due to intraventricular inflammatory cysts. 4, 17, 53 Some benefit may be realized from dexamethasone administered in therapeutic declining-dose therapy. 5, 9, 31, 38 A VP shunt is usually required in patients with chronic hydrocephalus and increased ICP. 14 The indications for excision of the viable cyst(s) include the following: 1) significant mass effect; 2) obstruction of CSF flow; 3) shunt placement precluded by the cyst; and 4) uncertain diagnosis .
14 Fourth ventricular viable cysts should typically undergo extirpation because they may cause brainstem compression even after insertion of a VP shunt. 33 Standard neurosurgical approaches are performed depending on the cyst location, including 1) transcortical for lateral ventricle cysts; 2) transcallosal or transcortical for third ventricle cysts; and 3) midline suboccipital for fourth ventricle cysts. 4, 17, 32, 51 The prudent neurosurgeon takes into account the possibility that a cyst may migrate between the time of diagnosis and surgery. 23 Cyst migration must be ruled out by examining a CT or MR image obtained immediately before surgery. 52, 53 Multiple cysts and multiple obstructions with loculated hydrocephalus may require multiple ventricular catheters to drain the separate loculations. 3 Patients harboring intraventricular cysts without hydrocephalus require close observation in case acute obstruction occurs and emergency shunt surgery becomes necessary.
Insertion of a shunt remains the primary therapy for inflammatory IVNCC, despite frequent shunt-related complications in these patients. Ventriculoperitoneal shunt obstruction, either by cyst-related gelatinous material or by high CSF protein, is the most common complication. 41 Early shunt revision should be considered if the patient experiences no improvement after shunt insertion, and recurrent shunt obstruction by cyst material is another reason for excision of intraventricular cysts. 5, 14, 44 Although the authors of a recent report have noted success in using anthelmintic drugs without surgery in 33 patients with giant (Ͼ 5-cm-diameter) subarachnoid cysts, the role of anthelmintic therapy in IVNCC remains uncertain. 35 The use of anthelmintic drugs in conjunction with shunts has been advocated to eradicate viable cysts and to decrease the rate of shunt failures. 5, 44 The use of praziquantel, an isoquinoline with broad anthelmintic activity, is controversial in IVNCC, because earlier results were associated with a poor outcome. 49 Both therapeutic failures and successes with praziquantel have been demonstrated in the treatment of IVNCC. 2, 5, 19, 25, 29, 34, 36, 49 The recommended dose is 50 mg/kg/day for 14 days, with concomitant use of dexamethasone. Albendazole, a benzimidazole with proven antiparasitic properties, has been used to treat IVNCC successfully. 18, 19, 22, 46 Intraventricular cysts may disappear within 3 months after treatment. 18, 19, 21, 46 The dose is 15 mg/kg/day for 15 days. The daily dose is divided into three administrations, with concomitant use of dexamethasone, in two courses given 1 month apart. Intermittent long-term steroid therapy may reduce the incidence of shunt failures. 48 Intraventricular neurocysticercosis may respond favorably to praziquantel or albendazole, or the favorable response may be due to the natural history of the disease. There is an inflammatory reaction similar to that seen with the natural death of the larva when the cyst larvae die following anthelmintic therapy. 12, 40 The scarring and granulomatous ependymitis may lead to acute hydrocephalus. Some authors therefore have questioned the effectiveness of anthelmintic therapy in IVNCC, even suggesting that such treatment is associated with an increase in long-term sequelae. 12 To resolve the debate regarding anthelmintic therapy in IVNCC, collaborative clinical trials are needed to evaluate specific medical treatments for IVNCC as well as to develop a better understanding of its clinical course. 12, 40 Two beneficial effects of anthelmintic drugs are the destruction of 1) associated viable parenchymal cysts, and 2) the intestinal parasite that may be a source of recurrent autoinfection.
Prognosis of NCC
In patients with IVNCC who undergo insertion of a VP shunt or resection of intraventricular cysts improvement typically occurs with resolution of the hydrocephalus. 54 Intraventricular neurocysticercosis, however, can be fatal with a mortality rate of 13% in patients with acute hydrocephalus. 53 Because the mass effect of a cyst in the posterior fossa is less well tolerated than in supratentorial sites, the prognosis for patients with fourth ventricular cysts is guarded. Fourth ventricular cysts usually present in the inflammatory state, with edema and adhesion to the adjacent tissue making resection of the entire lesion difficult. Shunt surgery does not always ensure a good prognosis. 44 Hydrocephalus recurs in some patients with IVNCC, even after the cysts have disappeared. 15, 18, 19, 28 Although reinfection occurs occasionally, more commonly the reason is CSF obstruction by chronic adhesions and thickening from involutional cysts. This emphasizes the need for aggressive initial treatment in these patients, including shunt therapy.
CONCLUSIONS
Intraventricular neurocysticercosis continues to be a potentially fatal condition in which the rate of permanent morbidity is high. Although active, viable intraventricular cysts do not produce a host reaction, they can obstruct CSF flow, leading to the complex clinical syndromes of hydrocephalus. The cysts can migrate throughout the ventricular system, inducing acute intermittent or permanent increased ICP and hydrocephalus. There is a local granulomatous ependymitis and generalized ventriculitis when the larvae die, resulting in hydrocephalus, increased ICP, and meningoencephalitis.
Neuroimaging (CT and MR imaging) remains the most important diagnostic study for IVNCC, especially if cysts in different stages of evolution are found. Enzyme-linked immunoelectrotransfer blot in both serum and CSF is positive in more than 80% of patients with meningeal irritation due to inflammatory intraventricular cysts.
The treatment of IVNCC is symptom specific. Dexamethasone may alleviate the increased ICP, cerebral edema, and inflammation. Both success and failure have been reported in conjunction with anthelmintic medications (albendazole or praziquantel). These medications hasten the evolution of intraventricular viable cysts, which may trigger an inflammatory response similar to that seen with the natural death of the parasite. Thus, long-term sequelae may result either with or without the use of anthelmintic medications.
Acute hydrocephalus is treated with a ventriculostomy followed by placement of a VP shunt. In patients with chronic hydrocephalus associated with intraventricular cysts, the selection of a VP shunt, resection of the cysts, and anthelmintic therapy may challenge the common sense, experience, and judgment of the most experienced physician.
